Carmat S.A. (CKMTF) Research

Carmat S.A. is dedicated to engineering and producing cutting-edge total artificial hearts. These innovative devices are developed to aid patients afflicted with severe, end-stage biventricular heart failure, serving markets in France and across the globe. The company was established in 2008 and operates from its primary base in Vélizy-Villacoublay, France.

Market snapshot

Symbol
CKMTF
Price
$12.75
Day change
-50.96%
Market cap
$6.4M
P/E ratio
-0.04x
52-week range
12.75-12.75
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Adocia S.A. (ADOIF)
  • Anteris Technologies Ltd (AMEUF)
  • E-therapeutics Plc (ETXPF)
  • Japan Medical Dynamic Marketing, Inc. (JMDMF)
  • Kiaro Holdings Corp. (KIARF)
  • Mind Cure Health Inc. (MCURF)
  • Nova Cannabis Inc. (NVACF)
  • Respiri Limited (RSHUF)

Open Carmat S.A. (CKMTF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.